首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷核子醫學

核子醫學掃描術診斷設備市場規模、佔有率和成長分析（按技術、產品類型、應用、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1897348

核子醫學掃描術診斷設備市場規模、佔有率和成長分析（按技術、產品類型、應用、最終用戶和地區分類）—2026-2033年產業預測

Nuclear Imaging Devices Market Size, Share, and Growth Analysis, By Technology (Single-Photon Emission Computed Tomography, Positron Emission Tomography ), By Product Type, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球核子醫學掃描術診斷設備市場規模預計在 2024 年達到 24.7 億美元，從 2025 年的 26.6 億美元成長到 2033 年的 47.4 億美元，在預測期（2026-2033 年）內複合年成長率為 7.5%。

全球核子醫學掃描術診斷市場持續穩定擴張，這主要得益於醫學影像技術的進步、慢性病盛行率的上升以及對非侵入性診斷方法日益成長的需求。人口老化加劇了老齡化相關疾病的易感性，同時核子醫學掃描術診斷在腫瘤學、心臟病學和神經病學領域的應用不斷拓展，也進一步推動了這一成長。 PET或SPECT與CT結合的混合影像系統的出現，透過整合解剖和功能訊息，顯著提升了診斷能力。此外，人工智慧（AI）和機器學習的應用也顯著提高了診斷的準確性和效率。儘管高成本和有限的報銷管道等挑戰依然存在，但醫療創新、地理擴張和策略合作仍蘊藏著巨大的機會。

推動全球核子醫學掃描術診斷設備市場發展的因素

全球核子醫學影像市場的發展主要得益於混合系統和分子影像等先進成像技術的湧現。這些技術顯著提高了診斷的準確性和效率，使醫療專業人員能夠全面了解各種器官和組織的功能，最終有助於改善患者的治療效果。此外，將人工智慧 (AI) 和機器學習演算法融入這些影像系統，進一步提升了影像品質和診斷潛力。因此，這些發展徹底改變了核子醫學掃描術診斷領域，使其成為現代醫療實踐和患者照護的關鍵組成部分。

全球核子醫學掃描術診斷設備市場面臨的限制因素

全球核子醫學掃描術診斷設備市場面臨許多挑戰，主要原因是這些設備需要大量的資金投入，包括資本支出、安裝和持續維護。高成本構成了一大障礙，尤其是在醫療預算有限的發展中地區。此外，成像過程中使用的放射性同位素的相關費用也加重了整體經濟負擔。這種高昂的價格結構會阻礙市場准入，並限制核醫影像技術的廣泛應用，尤其是在資源有限的醫療機構中。解決這些成本問題並探索更經濟的解決方案對於推動市場成長至關重要。

核子醫學掃描術診斷設備市場的全球趨勢

全球核子醫學掃描術診斷市場的一個顯著趨勢是混合影像系統的應用，這類系統整合了多種影像模式，例如PET和SPECT與CT和MRI。這種融合技術能夠在一次檢查中同時提供解剖和功能訊息，從而增強診斷能力。隨著醫療專業人員對疾病特徵分析和治療方案製定的日益重視，這些技術的整合有望提升患者照護水準。此外，能夠準確識別異常並評估其代謝活性（同時考慮鄰近組織）的能力正在推動市場需求，進而促進技術進步和市場成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

GE HealthCare Technologies（United States）
Siemens Healthineers（Germany）
Philips Healthcare（Netherlands）
Canon Medical Systems Corporation（Japan）
Neusoft Medical Systems Co., Ltd.（China）
Mediso Ltd.（Hungary）
Digirad Corporation（United States）
CMR Naviscan Corporation（United States）
Shimadzu Corporation（Japan）
PerkinElmer（United States）
MILabs BV（Netherlands）
MR Solutions Ltd.（United Kingdom）
SurgicEye GmbH（Germany）
Triad Isotopes（United States）
Cardinal Health（United States）
Lantheus Holdings（United States）
Medtronic（United States）
Bayer（Germany）
SHINE Technologies（United States）

結論與建議

簡介目錄

Product Code: SQMIG35A2604

Global Nuclear Imaging Devices Market size was valued at USD 2.47 Billion in 2024 and is poised to grow from USD 2.66 Billion in 2025 to USD 4.74 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The global nuclear imaging devices market is experiencing robust expansion fueled by advancements in medical imaging technologies, a rising prevalence of chronic conditions, and an increasing demand for non-invasive diagnostic methods. This growth is further propelled by the aging population, which is more susceptible to age-related illnesses, and the broader applications of nuclear imaging in oncology, cardiology, and neurology. The emergence of hybrid imaging systems that integrate PET or SPECT with CT is enhancing diagnostic capabilities by delivering combined anatomical and functional insights. Furthermore, the incorporation of artificial intelligence and machine learning significantly boosts accuracy and efficiency. Although challenges such as high costs and limited reimbursement options persist, there are substantial opportunities for innovation, geographic expansion, and strategic alliances within the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nuclear Imaging Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nuclear Imaging Devices Market Segments Analysis

Global Nuclear Imaging Devices Market is segmented by Technology, Product Type, Application, End User and region. Based on Technology, the market is segmented into Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET). Based on Product Type, the market is segmented into PET Devices, SPECT Devices and Planar Imaging Devices. Based on Application, the market is segmented into Oncology, Cardiology, Neurology and Others. Based on End User, the market is segmented into Hospitals, Imaging Centers, Academic and Research Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nuclear Imaging Devices Market

The Global Nuclear Imaging Devices market is driven by the emergence of cutting-edge imaging technologies, including hybrid systems and molecular imaging, which significantly improve the accuracy and efficiency of diagnostics. These innovations empower healthcare practitioners to gather comprehensive insights into the functioning of various organs and tissues, thereby enhancing patient outcomes. Moreover, the incorporation of artificial intelligence and machine learning algorithms into these imaging devices further elevates image quality and diagnostic potential. As a result, these developments are transforming the landscape of nuclear imaging, making it a crucial component in modern medical practice and patient care.

Restraints in the Global Nuclear Imaging Devices Market

The Global Nuclear Imaging Devices market faces notable challenges primarily due to the substantial financial investment required for capital expenditures, installation, and continuous maintenance of these devices. The elevated costs present obstacles, particularly in developing regions where healthcare budgets are constrained. Furthermore, the expense associated with radioactive isotopes utilized in imaging procedures compounds the overall financial burden. This high pricing structure can deter market entry and restrict the widespread adoption of nuclear imaging technologies, especially in healthcare facilities grappling with limited resources. To facilitate market growth, it is crucial to address these cost-related issues and explore more affordable solutions.

Market Trends of the Global Nuclear Imaging Devices Market

The Global Nuclear Imaging Devices market is witnessing a significant trend toward the adoption of hybrid imaging systems, which integrate various imaging modalities such as PET and SPECT with CT or MRI. This convergence enhances diagnostic capabilities by providing both anatomical and functional insights in a single examination. As healthcare professionals increasingly seek improved disease characterization and treatment planning, the integration of these technologies is poised to elevate patient care standards. Additionally, the ability to accurately locate abnormalities and assess their metabolic activity while considering adjacent tissues is driving demand, thereby fueling advancements and growth within the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Nuclear Imaging Devices Market Size by Technology & CAGR (2026-2033)

Market Overview
Single-Photon Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)

Global Nuclear Imaging Devices Market Size by Product Type & CAGR (2026-2033)

Market Overview
PET Devices
- Standalone PET
- PET/CT
- PET/MRI
SPECT Devices
- Standalone SPECT
- SPECT/CT
- SPECT/MRI
Planar Imaging Devices

Global Nuclear Imaging Devices Market Size by Application & CAGR (2026-2033)

Market Overview
Oncology
Cardiology
Neurology
Others

Global Nuclear Imaging Devices Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Imaging Centers
Academic and Research Centers
Others

Global Nuclear Imaging Devices Market Size & CAGR (2026-2033)

North America (Technology, Product Type, Application, End User)
- US
- Canada
Europe (Technology, Product Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Product Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Product Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Product Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

GE HealthCare Technologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neusoft Medical Systems Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mediso Ltd. (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Digirad Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CMR Naviscan Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MILabs B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MR Solutions Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SurgicEye GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Triad Isotopes (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lantheus Holdings (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SHINE Technologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments